Leerink Partners Starts Invuity (IVTY) at Outperform

Leerink Partners initiates coverage on Invuity (NASDAQ: IVTY) with a Outperform rating and a price target of $19.00.

Analyst Richard Newitter commented, "We initiate with an OP on Invuity (IVTY), an early-stage MedTech company with an advanced photonics solution to enhance visualization capabilities during surgery. Our $19 PT is based on a 5.3x '16E EV/Sales multiple (supported by DCF)--a level warranted in our view given IVTY's large market opportunity & above-avg. growth prospects."

For an analyst ratings summary and ratings history on Invuity click here. For more ratings news on Invuity click here.

Shares of Invuity closed at $14.34 yesterday.

You May Also Be Interested In

• BofA Securities Starts Dollarama Inc. (DOL:CN) (DLMAF) at Buy
• Glenmark Pharmaceuticals Ltd. (GNP:IN) PT Raised to INR2,750 at Investec
• Adobe (ADBE) PT Lowered to $245 at TD Cowen